A new study has found that discontinuing beta-blockers — long considered a lifelong medication for myocardial infarction (MI) patients — does not increase the risk of recurrence or death.
Study Finds Heart Attack Patients May Safely Stop Beta-Blockers
Prof. Han Joo-yong's Team at Samsung Seoul Hospital · Suggests Beta-Blocker Discontinuation Possible for Stable Post-MI Patients · Randomized Controlled Trial Validates Earlier Large-Scale Observational Study
Culture||
By Ahn Kyung-jin, Medical Correspondent
Related Video
AI-translated from Korean. Quotes from foreign sources are based on Korean-language reports and may not reflect exact original wording.